Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and voriconazole

pyrroles has been researched along with voriconazole in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Bhamidipati, RK; Mullangi, R; Srinivas, NR1
Birch, M; Buil, JB; Law, D; Meis, JF; Melchers, WJG; Rijs, AJMM; Verweij, PE1
Box, H; Colombo, AL; Hope, WW; Johnson, A; Kolamunnage-Dona, R; Livermore, J; McEntee, L; Negri, CE; Ramos-Martín, V; Schwartz, JA; Whalley, S1
Chen, F; Geng, P; Jiang, H; Liu, B; Meng, D; Shen, J; Wang, B; Wang, S; Zhou, Q; Zhou, Y1
Chang, YC; Kwon-Chung, KJ; Liu, H; Seyedmousavi, S; Xi, L; Zhang, J1
Buer, J; Dittmer, S; Furnica, DT; Kirchhoff, L; Rath, PM; Steinmann, E; Steinmann, J1

Other Studies

6 other study(ies) available for pyrroles and voriconazole

ArticleYear
Interspecies scaling of urinary excretory amounts of nine drugs belonging to different therapeutic areas with diverse chemical structures - accurate prediction of the human urinary excretory amounts.
    Xenobiotica; the fate of foreign compounds in biological systems, 2017, Volume: 47, Issue:2

    Topics: Animals; Benzodiazepines; Carbamates; Carbazoles; Cephapirin; Humans; Indoles; Labetalol; Nevirapine; Olanzapine; Pharmaceutical Preparations; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Species Specificity; Voriconazole

2017
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9

    Topics: Acetamides; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Nitriles; Piperazines; Point Mutation; Pyridines; Pyrimidines; Pyrroles; Triazoles; Voriconazole

2017
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
    The Journal of infectious diseases, 2018, 03-13, Volume: 217, Issue:7

    Topics: Acetamides; Animals; Antifungal Agents; Aspergillus flavus; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Invasive Pulmonary Aspergillosis; Mice; Piperazines; Pyrimidines; Pyrroles; Triazoles; Voriconazole

2018
Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Male; Microsomes, Liver; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides; Tandem Mass Spectrometry; Voriconazole

2020
Antifungal Susceptibility Profiles of Olorofim (Formerly F901318) and Currently Available Systemic Antifungals against Mold and Yeast Phases of
    Antimicrobial agents and chemotherapy, 2021, 05-18, Volume: 65, Issue:6

    Topics: Acetamides; Antifungal Agents; China; Microbial Sensitivity Tests; Piperazines; Pyrimidines; Pyrroles; Saccharomyces cerevisiae; Talaromyces; Voriconazole

2021
Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6

    Topics: Acetamides; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Piperazines; Pyrimidines; Pyrroles; Voriconazole

2022